/MDMA.CN
MDMA.CN Stock - Pharmala Biotech Holdings Inc.
Healthcare|BiotechnologyCNQ
$0.12+15.00%
+$0.01 (+15.00%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.47
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.13
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MDMA.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.11 – $0.12
TARGET (TP)$0.13
STOP LOSS$0.11
RISK/REWARD1:3.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.77
52W High$0.33
52W Low$0.09
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.04M | $532,003 | $78,070 | N/A |
| Gross Profit | $887,441 | $454,099 | $75,782 | $-303 |
| Gross Margin | 85.7% | 85.4% | 97.1% | N/A |
| Operating Income | $-643,566 | $-762,950 | $-985,583 | $-2,509,066 |
| Net Income | $-823,596 | $-779,813 | $-985,583 | $-2,509,066 |
| Net Margin | -79.6% | -146.6% | -1262.4% | N/A |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.03 |
Company Overview
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MDMA.CNBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q4 2023
EPS Surprise History
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Nov 30, 2023 | — | $0.00 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 28, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 30, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 31, 2022 | — | $-0.00 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about MDMA.CN
What is MDMA.CN's current stock price?
Pharmala Biotech Holdings Inc. (MDMA.CN) is currently trading at $0.12 per share. The stock has moved +15.00% today.
What is the analyst price target for MDMA.CN?
No analyst price targets are currently available for this stock.
What sector is Pharmala Biotech Holdings Inc. in?
Pharmala Biotech Holdings Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CNQ exchange.
What is MDMA.CN's market cap?
Pharmala Biotech Holdings Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does MDMA.CN pay dividends?
No, Pharmala Biotech Holdings Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBETR.CN
BetterLife Pharma Inc.
$0.05
Mkt Cap: $0.0B
BLAB.CN
Britannia Life Sciences Inc.
$0.09
Mkt Cap: $0.0B
CHS.V
Comprehensive Healthcare Systems, Inc.
$0.58
Mkt Cap: $0.0B
GLOW.CN
Glow Lifetech Corp.
$0.06
Mkt Cap: $0.0B
HEM.V
Hemostemix Inc.
$0.09
Mkt Cap: $0.0B
MPH.V
Medicure Inc.
$1.25
Mkt Cap: $0.0B
MRVL.V
Marvel Biosciences Corp.
$0.14
Mkt Cap: $0.0B
PHRM.CN
PharmaTher Holdings Ltd.
$0.10
Mkt Cap: $0.0B
PREV.CN
PreveCeutical Medical Inc.
$0.02
Mkt Cap: $0.0B
TRIP.CN
Red Light Holland Corp.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to MDMA.CN for comparison